- +1-315-215-1633
- sales@thebrainyinsights.com
The global blood glucose monitoring devices market was valued at USD 12.78 billion in 2022, which is anticipated to expand at a CAGR of 8.42% from 2023 to 2032. Blood glucose observation helps to recognise patterns in the variation of blood sugar (glucose) levels that occur in return to exercise, diet, pathological processes, and medications linked with blood glucose variations, for instance diabetes mellitus. Glucose is a sugar which a person's body utilities as a source of strength. Unless a person has diabetes, the body adjusts the quantity of glucose in the blood. A person with diabetes might need special nutrition and medicines to manage blood glucose. Abnormally low or high blood glucose range can possibly lead to life-threatening situations, both chronic and acute.
Blood sugar (or blood glucose) is the primary sugar found in the blood. Blood glucose is a primary source of energy for the body. It originates from the food we consume. The body breaks down most of that food stuff into glucose and emits it into the bloodstream. As the blood glucose rises, it indicates the pancreas to discharge insulin. The hormone that assists glucose to get into the cells to be exploited for energy is insulin. Blood glucose inspection is a very important aspect of controlling diabetes, specifically for people who are suffering from type-1 diabetes and individuals who take insulin. A person can examine their blood sugar by employing test strips and a glucose measuring device or a CGM (continuous glucose monitoring) system. Healthcare providers assist in determining the frequency and timing for checking blood glucose. The most conventional way to examine blood glucose level in home settings is by using a blood glucose meter. A blood sugar meter assesses the quantity of glucose in a minute sample of blood, generally from the fingertip. CGM (continuous glucose monitoring) is alternative way to check glucose readings. Most continuous glucose monitoring systems use a small sensor that is implanted under the skin of an individual. The sensor determines glucose level of an individual at regular intervals. It can display changes in the glucose level of a person right through the day and night. A continuous glucose monitoring system is specifically useful for individuals who take insulin and have troubles with low blood sugar. High levels of blood glucose is termed as hyperglycemia. Indications of high blood glucose levels include feeling weak or tired, feeling thirsty, headaches, blurred vision, and frequent urinating. The condition of low blood glucose is called hypoglycemia and it occurs when the blood glucose level falls below what is healthful for an individual. For several people living with diabetes, this implies a blood sugar reading lesser than 70 mg/dL. Lesser blood sugar levels can be commonplace in individuals with type 1 diabetes and individuals with type 2 diabetes who consume certain diabetes medications. Low level of blood glucose can be hazardous and must be treated as early as possible.
Get an overview of this study by requesting a free sample
Rise in occurrence of diabetes- Diabetes mellitus indicates a grouping of disorders that affect in what manner the body utilizes blood glucose (sugar). Glucose is a principal source of energy for cells that form tissues and muscles. Glucose is also the main source of fuel of brain. The major cause of diabetes differs by type. However, no matter which type of diabetes a person has, it can result in extra sugar in blood. Excessive sugar in the blood may lead to major health troubles. Type-1 diabetes can commence at any age. However, it often begins during teen years or even childhood. The more common type is type-2 diabetes, and it can arise at any age. Type-2 diabetes is although more prevalent in individuals older than 40. However, type-2 diabetes is constantly increasing in children. Diabetes is a prominent cause of kidney failure, blindness, lower limb amputation, stroke, and heart attacks.
Between the years 2000 and 2019, there was a 3% rise in diabetes death rates by age. Diabetes and kidney disorders caused due to diabetes resulted in an estimated 2 million mortalities in 2019. As per the CDC (Centers for Disease Control and Prevention), just above 37 million individuals in the United States have diabetes. The IDF Diabetes Atlas (2021) discloses that 10.5% of the adult (20-79 years) populace is suffering from diabetes, with nearly half ignorant that they are living with the disorder. By the year 2045, International Diabetes Federation (IDF) estimates show that nearly 783 million (1 in 8 adults) will be suffering from diabetes, a rise of 46%. More than 90% of diabetics have type 2 diabetes, which is led by demographic, socio-economic, genetic, and environmental factors. Blood glucose (blood sugar) monitoring is the chief tool to discover if blood glucose levels are inside the target range. Thus, rise in diabetes cases is expected to drive the growth of global blood glucose monitoring devices market.
Increasing popularity of continuous glucose monitors- Individuals living with diabetes have to monitor their blood glucose (sugar), a job conventionally done with the help of glucometers by pricking the finger at regular interval for drops of blood. However, over the last few years, technology such as CGM (continuous glucose monitoring) is on the rise. A latest study has discovered that prediabetes can be detected by using CGMs (continuous glucose monitors). This process could possibly identify individuals with early indications of prediabetes earlier than it would have been identified with a blood glucose examination. This could encourage individuals to make lifestyle variations earlier in the advancement of the disorder. Continuous glucose monitors are devices that evaluate blood glucose levels in almost real time. The sensors for such devices are fixed to the skin with a bonding patch and obtain blood glucose readings exclusive of the need for conventional fingerstick examinations. Such devices quantify blood sugar right through the day and trace variations, like spikes in blood glucose afterwards a meal or in case blood sugar declines.
Rigorous regulatory guidelines- The blood glucose monitoring devices products must go through a rigorous process for receiving approval. The testing products are checked on multiple parameters and have to comply with the mandatory guidelines. This is a time consuming and capital-intensive process.
The regions analysed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the most significant global Blood Glucose Monitoring Devices market, with a 38.21% market revenue share in 2022. Factors such as high awareness, availability of latest products, presence of market leading companies in the region, increasing use of continuous glucose monitors, and high spending capacity are expected to maintain the dominance of North America in the global blood glucose monitoring devices market.
North America Region Blood Glucose Monitoring Devices Market Share in 2022 - 38.21%
www.thebrainyinsights.com
Check the geographical analysis of this market by requesting a free sample
The product type segment is divided into continuous glucose monitoring devices and self-monitoring devices. Continuous glucose monitoring devices have been further segmented into transmitter and receiver, sensors, and insulin pumps. Self-monitoring devices have been further segmented into Blood glucose meter, testing strips, and lancets. Self-monitoring devices segment dominated, with a market share of around 68.04% in 2022. Easy availability is one of the major factors responsible for the high market share of self-monitoring devices.
The patient type segment is divided into type-2 diabetes and type-1 diabetes. The type-2 diabetes segment dominated the patient-type segment due to the high incidence of type-2 diabetes.
The end-use segment is divided into home/self care, hospitals, and diagnostic centers. The hospitals segment dominated the end-use segment.
Report Description:
| Attribute | Description |
|---|---|
| Market Size | Revenue (USD Billion) |
| Market size value in 2022 | USD 12.78 Billion |
| Market size value in 2032 | USD 27.60 Billion |
| CAGR (2023 to 2032) | 8.42% |
| Historical data | 2019-2021 |
| Base Year | 2022 |
| Forecast | 2023-2032 |
| Region | The regions analyzed for the market are Asia Pacific, Europe, South America, North America, and Middle East & Africa. Furthermore, the regions are further analyzed at the country level. |
| Segments | Product Type, Type, Patient Type, End-Use |
As per The Brainy Insights, the size of the blood glucose monitoring devices market was valued at USD 12.78 Billion in 2022 & USD 27.60 Billion by 2032.
Global blood glucose monitoring devices market is growing at a CAGR of 8.42% during the forecast period 2023-2032.
North America region emerged as the largest market for the blood glucose monitoring devices.
The growing occurrence of diabetes is a significant driving factor for the growth of the blood glucose monitoring devices market.
The increasing popularity of continuous glucose monitors is a significant opportunity for the growth of the blood glucose monitoring devices market.
Rigorous regulatory guidelines is a significant challenging factor for the growth of the blood glucose monitoring devices market.
1. Introduction
1.1. Objective of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis By Product Type
4.3.2. Market Attractiveness Analysis By Type
4.3.3. Market Attractiveness Analysis By Patient Type
4.3.4. Market Attractiveness Analysis By End-Use
4.3.5. Market Attractiveness Analysis By Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.2.1. The rise in occurrence of diabetes
5.3. Opportunities
5.3.1. The increasing popularity of continuous glucose monitors
5.4. Challenges
5.4.1. Rigorous regulatory guidelines
6. Global Blood Glucose Monitoring Devices Market Analysis and Forecast, By Product Type
6.1. Segment Overview
6.2. Continuous Glucose Monitoring Devices
6.2.1. Transmitter and Receiver
6.2.2. Sensors
6.2.3. Insulin Pumps
6.3. Self-monitoring Devices
6.3.1. Blood Glucose Meter
6.3.2. Testing Strips
6.3.3. Lancets
7. Global Blood Glucose Monitoring Devices Market Analysis and Forecast, By Type
7.1. Segment Overview
7.2. Invasive
7.3. Non-invasive
8. Global Blood Glucose Monitoring Devices Market Analysis and Forecast, By Patient Type
8.1. Segment Overview
8.2. Type-2 Diabetes
8.3. Type-1 Diabetes
9. Global Blood Glucose Monitoring Devices Market Analysis and Forecast, By End-Use
9.1. Segment Overview
9.2. Home/Self Care
9.3. Hospitals
9.4. Diagnostic Centers
10. Global Blood Glucose Monitoring Devices Market Analysis and Forecast, By Regional Analysis
10.1. Segment Overview
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.2.3. Mexico
10.3. Europe
10.3.1. Germany
10.3.2. France
10.3.3. U.K.
10.3.4. Italy
10.3.5. Spain
10.4. Asia-Pacific
10.4.1. Japan
10.4.2. China
10.4.3. India
10.5. South America
10.5.1. Brazil
10.6. Middle East and Africa
10.6.1. UAE
10.6.2. South Africa
11. Global Blood Glucose Monitoring Devices Market-Competitive Landscape
11.1. Overview
11.2. Market Share of Key Players in the Blood Glucose Monitoring Devices Market
11.2.1. Global Company Market Share
11.2.2. North America Company Market Share
11.2.3. Europe Company Market Share
11.2.4. APAC Company Market Share
11.3. Competitive Situations and Trends
11.3.1. Product Launches and Developments
11.3.2. Partnerships, Collaborations, and Agreements
11.3.3. Mergers & Acquisitions
11.3.4. Expansions
12. Company Profiles
12.1. Medtronic plc
12.1.1. Business Overview
12.1.2. Company Snapshot
12.1.3. Company Market Share Analysis
12.1.4. Company Product Portfolio
12.1.5. Recent Developments
12.1.6. SWOT Analysis
12.2. Abbott Laboratories
12.2.1. Business Overview
12.2.2. Company Snapshot
12.2.3. Company Market Share Analysis
12.2.4. Company Product Portfolio
12.2.5. Recent Developments
12.2.6. SWOT Analysis
12.3. Ascensia Diabetes Care
12.3.1. Business Overview
12.3.2. Company Snapshot
12.3.3. Company Market Share Analysis
12.3.4. Company Product Portfolio
12.3.5. Recent Developments
12.3.6. SWOT Analysis
12.4. F. Hoffmann-La Roche Ltd
12.4.1. Business Overview
12.4.2. Company Snapshot
12.4.3. Company Market Share Analysis
12.4.4. Company Product Portfolio
12.4.5. Recent Developments
12.4.6. SWOT Analysis
12.5. Dexcom, Inc.
12.5.1. Business Overview
12.5.2. Company Snapshot
12.5.3. Company Market Share Analysis
12.5.4. Company Product Portfolio
12.5.5. Recent Developments
12.5.6. SWOT Analysis
12.6. Novo Nordisk
12.6.1. Business Overview
12.6.2. Company Snapshot
12.6.3. Company Market Share Analysis
12.6.4. Company Product Portfolio
12.6.5. Recent Developments
12.6.6. SWOT Analysis
12.7. Sanofi
12.7.1. Business Overview
12.7.2. Company Snapshot
12.7.3. Company Market Share Analysis
12.7.4. Company Product Portfolio
12.7.5. Recent Developments
12.7.6. SWOT Analysis
12.8. Ypsomed Holdings
12.8.1. Business Overview
12.8.2. Company Snapshot
12.8.3. Company Market Share Analysis
12.8.4. Company Product Portfolio
12.8.5. Recent Developments
12.8.6. SWOT Analysis
12.9. Insulet Corporation
12.9.1. Business Overview
12.9.2. Company Snapshot
12.9.3. Company Market Share Analysis
12.9.4. Company Product Portfolio
12.9.5. Recent Developments
12.9.6. SWOT Analysis
12.10. Glysens Incorporated
12.10.1. Business Overview
12.10.2. Company Snapshot
12.10.3. Company Market Share Analysis
12.10.4. Company Product Portfolio
12.10.5. Recent Developments
12.10.6. SWOT Analysis
12.11. B. Braun Medical Ltd
12.11.1. Business Overview
12.11.2. Company Snapshot
12.11.3. Company Market Share Analysis
12.11.4. Company Product Portfolio
12.11.5. Recent Developments
12.11.6. SWOT Analysis
12.12. Terumo Europe NV
12.12.1. Business Overview
12.12.2. Company Snapshot
12.12.3. Company Market Share Analysis
12.12.4. Company Product Portfolio
12.12.5. Recent Developments
12.12.6. SWOT Analysis
12.13. LifeScan IP Holdings, LLC
12.13.1. Business Overview
12.13.2. Company Snapshot
12.13.3. Company Market Share Analysis
12.13.4. Company Product Portfolio
12.13.5. Recent Developments
12.13.6. SWOT Analysis
12.14. Nipro
12.14.1. Business Overview
12.14.2. Company Snapshot
12.14.3. Company Market Share Analysis
12.14.4. Company Product Portfolio
12.14.5. Recent Developments
12.14.6. SWOT Analysis
List of Table
1. Global Blood Glucose Monitoring Devices Market, By Product Type, 2019-2032 (USD Billion)
2. Global Continuous Glucose Monitoring Devices, Blood Glucose Monitoring Devices Market, By Region, 2019-2032 (USD Billion)
3. Global Self-monitoring Devices, Blood Glucose Monitoring Devices Market, By Region, 2019-2032 (USD Billion)
4. Global Blood Glucose Monitoring Devices Market, By Type, 2019-2032 (USD Billion)
5. Global Invasive, Blood Glucose Monitoring Devices Market, By Region, 2019-2032 (USD Billion)
6. Global Non-invasive, Blood Glucose Monitoring Devices Market, By Region, 2019-2032 (USD Billion)
7. Global Blood Glucose Monitoring Devices Market, By Patient Type, 2019-2032 (USD Billion)
8. Global Type-2 Diabetes, Blood Glucose Monitoring Devices Market, By Region, 2019-2032 (USD Billion)
9. Global Type-1 Diabetes, Blood Glucose Monitoring Devices Market, By Region, 2019-2032 (USD Billion)
10. Global Blood Glucose Monitoring Devices Market, By End-Use, 2019-2032 (USD Billion)
11. Global Home/Self Care, Blood Glucose Monitoring Devices Market, By Region, 2019-2032 (USD Billion)
12. Global Hospitals, Blood Glucose Monitoring Devices Market, By Region, 2019-2032 (USD Billion)
13. Global Diagnostic Centers, Blood Glucose Monitoring Devices Market, By Region, 2019-2032 (USD Billion)
14. Global Blood Glucose Monitoring Devices Market, By Region, 2019-2032 (USD Billion)
15. North America Blood Glucose Monitoring Devices Market, By Product Type, 2019-2032 (USD Billion)
16. North America Blood Glucose Monitoring Devices Market, By Type, 2019-2032 (USD Billion)
17. North America Blood Glucose Monitoring Devices Market, By Patient Type, 2019-2032 (USD Billion)
18. North America Blood Glucose Monitoring Devices Market, By End-Use, 2019-2032 (USD Billion)
19. U.S. Blood Glucose Monitoring Devices Market, By Product Type, 2019-2032 (USD Billion)
20. U.S. Blood Glucose Monitoring Devices Market, By Type, 2019-2032 (USD Billion)
21. U.S. Blood Glucose Monitoring Devices Market, By Patient Type, 2019-2032 (USD Billion)
22. U.S. Blood Glucose Monitoring Devices Market, By End-Use, 2019-2032 (USD Billion)
23. Canada Blood Glucose Monitoring Devices Market, By Product Type, 2019-2032 (USD Billion)
24. Canada Blood Glucose Monitoring Devices Market, By Type, 2019-2032 (USD Billion)
25. Canada Blood Glucose Monitoring Devices Market, By Patient Type, 2019-2032 (USD Billion)
26. Canada Blood Glucose Monitoring Devices Market, By End-Use, 2019-2032 (USD Billion)
27. Mexico Blood Glucose Monitoring Devices Market, By Product Type, 2019-2032 (USD Billion)
28. Mexico Blood Glucose Monitoring Devices Market, By Type, 2019-2032 (USD Billion)
29. Mexico Blood Glucose Monitoring Devices Market, By Patient Type, 2019-2032 (USD Billion)
30. Mexico Blood Glucose Monitoring Devices Market, By End-Use, 2019-2032 (USD Billion)
31. Europe Blood Glucose Monitoring Devices Market, By Product Type, 2019-2032 (USD Billion)
32. Europe Blood Glucose Monitoring Devices Market, By Type, 2019-2032 (USD Billion)
33. Europe Blood Glucose Monitoring Devices Market, By Patient Type, 2019-2032 (USD Billion)
34. Europe Blood Glucose Monitoring Devices Market, By End-Use, 2019-2032 (USD Billion)
35. Germany Blood Glucose Monitoring Devices Market, By Product Type, 2019-2032 (USD Billion)
36. Germany Blood Glucose Monitoring Devices Market, By Type, 2019-2032 (USD Billion)
37. Germany Blood Glucose Monitoring Devices Market, By Patient Type, 2019-2032 (USD Billion)
38. Germany Blood Glucose Monitoring Devices Market, By End-Use, 2019-2032 (USD Billion)
39. France Blood Glucose Monitoring Devices Market, By Product Type, 2019-2032 (USD Billion)
40. France Blood Glucose Monitoring Devices Market, By Type, 2019-2032 (USD Billion)
41. France Blood Glucose Monitoring Devices Market, By Patient Type, 2019-2032 (USD Billion)
42. France Blood Glucose Monitoring Devices Market, By End-Use, 2019-2032 (USD Billion)
43. U.K. Blood Glucose Monitoring Devices Market, By Product Type, 2019-2032 (USD Billion)
44. U.K. Blood Glucose Monitoring Devices Market, By Type, 2019-2032 (USD Billion)
45. U.K. Blood Glucose Monitoring Devices Market, By Patient Type, 2019-2032 (USD Billion)
46. U.K. Blood Glucose Monitoring Devices Market, By End-Use, 2019-2032 (USD Billion)
47. Italy Blood Glucose Monitoring Devices Market, By Product Type, 2019-2032 (USD Billion)
48. Italy Blood Glucose Monitoring Devices Market, By Type, 2019-2032 (USD Billion)
49. Italy Blood Glucose Monitoring Devices Market, By Patient Type, 2019-2032 (USD Billion)
50. Italy Blood Glucose Monitoring Devices Market, By End-Use, 2019-2032 (USD Billion)
51. Spain Blood Glucose Monitoring Devices Market, By Product Type, 2019-2032 (USD Billion)
52. Spain Blood Glucose Monitoring Devices Market, By Type, 2019-2032 (USD Billion)
53. Spain Blood Glucose Monitoring Devices Market, By Patient Type, 2019-2032 (USD Billion)
54. Spain Blood Glucose Monitoring Devices Market, By End-Use, 2019-2032 (USD Billion)
55. Asia Pacific Blood Glucose Monitoring Devices Market, By Product Type, 2019-2032 (USD Billion)
56. Asia Pacific Blood Glucose Monitoring Devices Market, By Type, 2019-2032 (USD Billion)
57. Asia Pacific Blood Glucose Monitoring Devices Market, By Patient Type, 2019-2032 (USD Billion)
58. Asia Pacific Blood Glucose Monitoring Devices Market, By End-Use, 2019-2032 (USD Billion)
59. Japan Blood Glucose Monitoring Devices Market, By Product Type, 2019-2032 (USD Billion)
60. Japan Blood Glucose Monitoring Devices Market, By Type, 2019-2032 (USD Billion)
61. Japan Blood Glucose Monitoring Devices Market, By Patient Type, 2019-2032 (USD Billion)
62. Japan Blood Glucose Monitoring Devices Market, By End-Use, 2019-2032 (USD Billion)
63. China Blood Glucose Monitoring Devices Market, By Product Type, 2019-2032 (USD Billion)
64. China Blood Glucose Monitoring Devices Market, By Type, 2019-2032 (USD Billion)
65. China Blood Glucose Monitoring Devices Market, By Patient Type, 2019-2032 (USD Billion)
66. China Blood Glucose Monitoring Devices Market, By End-Use, 2019-2032 (USD Billion)
67. India Blood Glucose Monitoring Devices Market, By Product Type, 2019-2032 (USD Billion)
68. India Blood Glucose Monitoring Devices Market, By Type, 2019-2032 (USD Billion)
69. India Blood Glucose Monitoring Devices Market, By Patient Type, 2019-2032 (USD Billion)
70. India Blood Glucose Monitoring Devices Market, By End-Use, 2019-2032 (USD Billion)
71. South America Blood Glucose Monitoring Devices Market, By Product Type, 2019-2032 (USD Billion)
72. South America Blood Glucose Monitoring Devices Market, By Type, 2019-2032 (USD Billion)
73. South America Blood Glucose Monitoring Devices Market, By Patient Type, 2019-2032 (USD Billion)
74. South America Blood Glucose Monitoring Devices Market, By End-Use, 2019-2032 (USD Billion)
75. Brazil Blood Glucose Monitoring Devices Market, By Product Type, 2019-2032 (USD Billion)
76. Brazil Blood Glucose Monitoring Devices Market, By Type, 2019-2032 (USD Billion)
77. Brazil Blood Glucose Monitoring Devices Market, By Patient Type, 2019-2032 (USD Billion)
78. Brazil Blood Glucose Monitoring Devices Market, By End-Use, 2019-2032 (USD Billion)
79. Middle East and Africa Blood Glucose Monitoring Devices Market, By Product Type, 2019-2032 (USD Billion)
80. Middle East and Africa Blood Glucose Monitoring Devices Market, By Type, 2019-2032 (USD Billion)
81. Middle East and Africa Blood Glucose Monitoring Devices Market, By Patient Type, 2019-2032 (USD Billion)
82. Middle East and Africa Blood Glucose Monitoring Devices Market, By End-Use, 2019-2032 (USD Billion)
83. UAE Blood Glucose Monitoring Devices Market, By Product Type, 2019-2032 (USD Billion)
84. UAE Blood Glucose Monitoring Devices Market, By Type, 2019-2032 (USD Billion)
85. UAE Blood Glucose Monitoring Devices Market, By Patient Type, 2019-2032 (USD Billion)
86. UAE Blood Glucose Monitoring Devices Market, By End-Use, 2019-2032 (USD Billion)
87. South Africa Blood Glucose Monitoring Devices Market, By Product Type, 2019-2032 (USD Billion)
88. South Africa Blood Glucose Monitoring Devices Market, By Type, 2019-2032 (USD Billion)
89. South Africa Blood Glucose Monitoring Devices Market, By Patient Type, 2019-2032 (USD Billion)
90. South Africa Blood Glucose Monitoring Devices Market, By End-Use, 2019-2032 (USD Billion)
List of Figures
1. Global Blood Glucose Monitoring Devices Market Segmentation
2. Blood Glucose Monitoring Devices Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Blood Glucose Monitoring Devices Market Attractiveness Analysis By Product Type
9. Global Blood Glucose Monitoring Devices Market Attractiveness Analysis By Type
10. Global Blood Glucose Monitoring Devices Market Attractiveness Analysis By Patient Type
11. Global Blood Glucose Monitoring Devices Market Attractiveness Analysis By End-Use
12. Global Blood Glucose Monitoring Devices Market Attractiveness Analysis By Region
13. Global Blood Glucose Monitoring Devices Market: Dynamics
14. Global Blood Glucose Monitoring Devices Market Share by Product Type (2023 & 2032)
15. Global Blood Glucose Monitoring Devices Market Share by Type (2023 & 2032)
16. Global Blood Glucose Monitoring Devices Market Share by Patient Type (2023 & 2032)
17. Global Blood Glucose Monitoring Devices Market Share by End-Use (2023 & 2032)
18. Global Blood Glucose Monitoring Devices Market Share by Regions (2023 & 2032)
19. Global Blood Glucose Monitoring Devices Market Share by Company (2022)
This study forecasts revenue at global, regional, and country levels from 2019 to 2032. The Brainy Insights has segmented the global blood glucose monitoring devices market based on below mentioned segments:
Global Blood Glucose Monitoring Devices by Product Type:
Global Blood Glucose Monitoring Devices by Type:
Global Blood Glucose Monitoring Devices by Patient Type:
Global Blood Glucose Monitoring Devices by End-Use:
Global Blood Glucose Monitoring Devices by Region:
Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision.
Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.
The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.
Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:
The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.
The data procurement stage involves in data gathering and collecting through various data sources.
This stage involves in extensive research. These data sources includes:
Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:
Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.
Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.
The supply side for a domain specific market is analysed by:
The demand side for the market is estimated through:
In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.
Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:
Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:
Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.
This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.
Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.
The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:
Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.
Free Customization
Fortune 500 Clients
Free Yearly Update On Purchase Of Multi/Corporate License
Companies Served Till Date
